An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
The purpose of the study is to determine whether an ingestion of a new renal multivitamin supplement can have a beneficial effect on bone and mineral adn inflammation issues related to patients on dialysis.
100 Clinical Results associated with Nephrian, Inc.
0 Patents (Medical) associated with Nephrian, Inc.
100 Deals associated with Nephrian, Inc.
100 Translational Medicine associated with Nephrian, Inc.